Categoría: Multiple Sclerosis
-
Stem cell therapy for multiple sclerosis: Xenia C.
Xenia C. tells how she can ride her horses again after receiving stem cell therapy for multiple sclerosis (MS) at the Stem Cell Institute in Panama City, Panama. «I have a life now…»
-
Multiple Sclerosis Treatment Success Using Mesenchymal Stem Cell-Secreted Factors in Animal Model
Stem cell researchers at Case Western Reserve have reported in Nature Magazine that the functional deficits caused by multiple sclerosis can be reduced by administering mesenchymal stem cell secreted factors. While previous studies have shown promising results using mesenchymal stem cells, this is the first time that such results have been reported without using the…
-
Legendary Texas Football Coach and Stem Cell Recipient Sam Harrell Returns to Coaching
In 2010, the debilitating effects of multiple sclerosis forced Sam Harrell to retire from his position as Head Football Coach at Ennis High School. But after receiving 3 courses of stem cell therapy at the Stem Cell Institute in Panama, Sam is returing to the gridiron once again. Brownwood Lion Head Coach, Bob Shipley announced…
-
Quality time: Former Ennis coach Sam Harrell is counting his blessings despite having multiple sclerosis
ENNIS, TX — Sam Harrell’s three state football championships are celebrated in his home office. He has pictures, trophies and balls, and even more memories. For 32 years, Harrell worked in a profession where success is measured by a scoreboard in front of thousands. These days, life’s little victories — unaccompanied by cheers or Gatorade…
-
Great Day in Ft. Worth for Stem Cell Team
Saturday, March 31 was the annual MS Walk in Ft Worth. This year, thanks to the Stem Cell Institute and some of the area stem cell patients, several of us MS sufferers and stem cell patients met for the Walk. Here’s a picture of several of us who have been to Panama, or Costa Rica,…
-
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR, Thompson AJ, Compston A, Scott MA, Miller DH, Chandran S. Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. Abstract BACKGROUND: More than half of patients with multiple sclerosis have progressive disease characterised by accumulating disability. The…